skip to the content

Clinical Trials

M2a Magnum Hip System

Protocol ID

05.09.162

Protocol Description

The purpose of this study is to evaluate the M2a Magnum Hip System, a new hip system that is approved by the FDA. This study will collect data related to the surgery. This data will include – demographic data, data about the surgery itself, clinical data on how patients feel and function before and after the surgery, radiographic data and any complications related to the surgery.

This data collection effort will document the clinical outcomes of the M2a Magnum Hip System. The data gathered will be collated and used to provide physicians clinical outcome, implant life span, and potential complications when using the M2a Magnum Hip System. The data will also provide feedback to designing engineers of the manufacturer – Biomet Inc.

Eligibility Criteria

Candidates for hip replacement surgery

Primary Investigator(s)

  • Eugene S. Krauss, MD

Contact Information

Ayal Segal, MD
(516) 674-1733
asegal@nshs.edu

Last Update

April 2, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Joints:
top
top